NEW YORK – TruDiagnostic said on Monday that its Lexington, Kentucky-based laboratory has received CLIA certification in 49 states.
The CLIA certification includes advanced registration in California, Maryland, Rhode Island, and Pennsylvania. TruDiagnostic said in a statement that it expects to receive final registration in New York next month. A spokesperson for the company noted that New York's Clinical Laboratory Evaluation Program required additional information beyond the federal requirements for CLIA certification.
TruDiagnostic also said it launched a new dual-facing portal interface with a focus on epigenetics and reporting test interpretations. The portal allows patients and providers to view test results, track data, and receive personalized recommendations based on individual epigenetic data.
The health data company plans to launch the second phase of the portal in the third quarter of 2021, with new features such as multiple interfaces with healthcare providers' electronic medical records, connections with wearable devices for remote health monitoring, and enhanced web-based reporting. Patients will be able to receive personalized nutrition and fitness recommendations, while providers can view interventional recommendations.
TruDiagnostic was founded in 2020 and focuses on multiomics and epigenetics, with an epigenetic database of DNA methylation markers and covariates. Its TruAge test measures a patient's biological age by looking at DNA methylation, according to the company's website.